Status:
COMPLETED
Is Fructose Linked to Adiposity in Babies?
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
San Francisco General Hospital
Conditions:
Obesity
Metabolic Syndrome
Eligibility:
FEMALE
18-40 years
Brief Summary
The obesity epidemic has reached down into the infant and toddler age group. Dietary indiscretion during pregnancy, particularly in our current food environment, is a major risk factor for both gestat...
Detailed Description
The "fetal origins hypothesis" suggests that an individual's risk for obesity and metabolic disorders begins in utero; that fetal or early postnatal exposure to environmental factors, such as maternal...
Eligibility Criteria
Inclusion
- Agreement to participate in all measurements
- Plans to remain in the area through delivery
- Ability to understand and give informed consent in either English or Spanish.
Exclusion
- Presence of diabetes prior to the index pregnancy
- Presence of gestational diabetes during a previous pregnancy
- Presence of diabetes or of other chronic metabolic disease such as cardiovascular disease, active thyroid disease, liver disease, pulmonary or psychiatric disorders, HIV
- Any disorder requiring diet therapy (i.e., renal insufficiency)
- Multiple gestation
- Prior history of intrauterine growth retardation
- Use of substances known to cause intrauterine growth retardation (e.g., smoking or drug use). -
- Once recruited, any ultrasonographic evidence of intrauterine growth retardation during the course of the pregnancy would also lead to exclusion.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01262781
Start Date
January 1 2011
End Date
January 1 2013
Last Update
April 10 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco General Hospital
San Francisco, California, United States, 94110